Chronic Hepatitis E Virus Infection during Lymphoplasmacytic Lymphoma and Ibrutinib Treatment.

Bruton’s tyrosine kinase chronification hepatitis E virus ibrutinib immunosuppression lymphoplasmacytic lymphoma

Journal

Pathogens (Basel, Switzerland)
ISSN: 2076-0817
Titre abrégé: Pathogens
Pays: Switzerland
ID NLM: 101596317

Informations de publication

Date de publication:
22 Aug 2019
Historique:
received: 18 07 2019
revised: 16 08 2019
accepted: 17 08 2019
entrez: 25 8 2019
pubmed: 25 8 2019
medline: 25 8 2019
Statut: epublish

Résumé

Hepatitis E virus (HEV) is an increasingly recognised pathogen, affecting several hundred thousand individuals in western countries each year. Importantly, the majority of immunocompromised individuals are not able to clear HEV but develop a chronic course of infection. In the case of lymphoma, which is an inherent immunosuppressive disease per se, chemotherapy can even further exacerbate the immunosuppressive status. As the mechanism of HEV chronification is barely understood, it is important to gain knowledge about the influence of chemotherapeutic drugs on the HEV replication cycle to guide rational clinical management of HEV infection in such patients. In this case report, a 70 year old man was diagnosed with lymphoplasmacytic lymphoma. As we observed the occurrence of chronic HEV after treatment with the Bruton's tyrosine kinase (BTK) inhibitor ibrutinib

Identifiants

pubmed: 31443360
pii: pathogens8030129
doi: 10.3390/pathogens8030129
pmc: PMC6789582
pii:
doi:

Types de publication

Case Reports

Langues

eng

Subventions

Organisme : This work was supported by a grant from the German Federal Ministry of Health with regard to a decision of the German Bundestag by the Federal Government
ID : CHED-project grant No: ZMVI1-2516-AUK-701 /BMG: 321-4471-02/157

Références

J Viral Hepat. 2016 Jul;23(7):512-21
pubmed: 26891712
J Hepatol. 2014 Dec;61(6):1418-29
pubmed: 25195557
N Engl J Med. 2014 Mar 20;370(12):1111-20
pubmed: 24645943
Curr Opin Virol. 2018 Oct;32:80-87
pubmed: 30384328
J Viral Hepat. 2018 Jun;25(6):752-758
pubmed: 29377436
Clin Infect Dis. 2010 Mar 1;50(5):e30-3
pubmed: 20113176
Bull Cancer. 2019 Jan;106(1):84-85
pubmed: 30579570
N Engl J Med. 2008 Feb 21;358(8):811-7
pubmed: 18287603
Acta Gastroenterol Belg. 2015 Dec;78(4):424-6
pubmed: 26712054
J Hepatol. 2019 Sep;71(3):465-472
pubmed: 31108159

Auteurs

Bernhard Schlevogt (B)

Department of Medicine B for Gastroenterology and Hepatology, University Hospital Muenster, 48149 Münster, Germany.

Volker Kinast (V)

Institute of Experimental Virology, TWINCORE Centre for Experimental and Clinical Infection Research, a Joint Venture between the Medical School Hannover (MHH) and the Helmholtz Centre for Infection Research (HZI), 30625 Hannover, Germany.
Department for Molecular and Medical Virology, Faculty of Medicine, Ruhr University Bochum, 44801 Bochum, Germany.

Julia Reusch (J)

Department of Medicine A, Hematology, Oncology and Pneumology, University Hospital Muenster, 48149 Münster, Germany.

Andrea Kerkhoff (A)

Department of Medicine A, Hematology, Oncology and Pneumology, University Hospital Muenster, 48149 Münster, Germany.

Dimas Praditya (D)

Institute of Experimental Virology, TWINCORE Centre for Experimental and Clinical Infection Research, a Joint Venture between the Medical School Hannover (MHH) and the Helmholtz Centre for Infection Research (HZI), 30625 Hannover, Germany.
Department for Molecular and Medical Virology, Faculty of Medicine, Ruhr University Bochum, 44801 Bochum, Germany.

Daniel Todt (D)

Department for Molecular and Medical Virology, Faculty of Medicine, Ruhr University Bochum, 44801 Bochum, Germany.

Hartmut H Schmidt (HH)

Department of Medicine B for Gastroenterology and Hepatology, University Hospital Muenster, 48149 Münster, Germany.

Eike Steinmann (E)

Department for Molecular and Medical Virology, Faculty of Medicine, Ruhr University Bochum, 44801 Bochum, Germany. eike.steinmann@ruhr-uni-bochum.de.

Patrick Behrendt (P)

Institute of Experimental Virology, TWINCORE Centre for Experimental and Clinical Infection Research, a Joint Venture between the Medical School Hannover (MHH) and the Helmholtz Centre for Infection Research (HZI), 30625 Hannover, Germany. Behrendt.Patrick@mh-hannover.de.
Department of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School, 30625 Hannover, Germany. Behrendt.Patrick@mh-hannover.de.
German Centre for Infection Research (DZIF), Partner-Site Hannover-Braunschweig, 30625 Hannover, Germany. Behrendt.Patrick@mh-hannover.de.

Classifications MeSH